Patents by Inventor Jonas Ödman

Jonas Ödman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20100291216
    Abstract: The present invention relates to pharmaceutical compositions for sustained release comprising a water soluble salt of the HMG-CoA reductase inhibitor fluvastatin as active ingredient, said composition being selected from the group comprising matrix formulations, diffusion-controlled membrane coated formulations; and combinations thereof.
    Type: Application
    Filed: June 8, 2010
    Publication date: November 18, 2010
    Inventors: Jan-Erik Löfroth, Jonas Ödman
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20100291217
    Abstract: The present invention relates to pharmaceutical compositions for sustained release comprising a water soluble salt of the HMG-CoA reductase inhibitor fluvastatin as active ingredient, said composition being selected from the group comprising matrix formulations, diffusion-controlled membrane coated formulations; and combinations thereof.
    Type: Application
    Filed: June 8, 2010
    Publication date: November 18, 2010
    Inventors: Jan-Erik Löfroth, Jonas Ödman
  • Pharmaceutical Compositions
    Publication number: 20080058399
    Abstract: The present invention provides pharmaceutical compositions comprising as an active ingredient candesartan or candesartan cilexetil, compositions exhibiting a relative bioavailability, measured as area under the curve, of more than 1.5.
    Type: Application
    Filed: September 5, 2007
    Publication date: March 6, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Bertil Abrahamsson, Jonas Odman